Atlas Trials

Effectiveness and Safety of the COVID-19 Vaccination for Patients With Liver Disease (CHESS2101)

Clinical trial NCT04883177 · COMPLETED

Trial details

NCT number
NCT04883177
Sponsor
Hepatopancreatobiliary Surgery Institute of Gansu Province
Status
COMPLETED
Study type
OBSERVATIONAL
COVID-19Liver DiseaseVaccine Reaction
Start date
2021-05-11
Primary completion
2022-01-01
Enrollment
1000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.